title: Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells.
abstract: Hantaviruses infect endothelial cells and cause 2 vascular permeability-based diseases. Pathogenic hantaviruses enhance the permeability of endothelial cells in response to vascular endothelial growth factor (VEGF). However, the mechanism by which hantaviruses hyperpermeabilize endothelial cells has not been defined. The paracellular permeability of endothelial cells is uniquely determined by the homophilic assembly of vascular endothelial cadherin (VE-cadherin) within adherens junctions, which is regulated by VEGF receptor-2 (VEGFR2) responses. Here, we investigated VEGFR2 phosphorylation and the internalization of VE-cadherin within endothelial cells infected by pathogenic Andes virus (ANDV) and Hantaan virus (HTNV) and nonpathogenic Tula virus (TULV) hantaviruses. We found that VEGF addition to ANDV- and HTNV-infected endothelial cells results in the hyperphosphorylation of VEGFR2, while TULV infection failed to increase VEGFR2 phosphorylation. Concomitant with the VEGFR2 hyperphosphorylation, VE-cadherin was internalized to intracellular vesicles within ANDV- or HTNV-, but not TULV-, infected endothelial cells. Addition of angiopoietin-1 (Ang-1) or sphingosine-1-phosphate (S1P) to ANDV- or HTNV-infected cells blocked VE-cadherin internalization in response to VEGF. These findings are consistent with the ability of Ang-1 and S1P to inhibit hantavirus-induced endothelial cell permeability. Our results suggest that pathogenic hantaviruses disrupt fluid barrier properties of endothelial cell adherens junctions by enhancing VEGFR2-VE-cadherin pathway responses which increase paracellular permeability. These results provide a pathway-specific mechanism for the enhanced permeability of hantavirus-infected endothelial cells and suggest that stabilizing VE-cadherin within adherens junctions is a primary target for regulating endothelial cell permeability during pathogenic hantavirus infection.
authors.affiliation: Department of Molecular Genetics & Microbiology, Stony Brook University, Life Sciences Room 126, Stony Brook, NY 11794-5222, USA.
authors.forename: Elena
authors.initials: E
authors.lastname: Gorbunova
authors.forename: Irina N
authors.initials: IN
authors.lastname: Gavrilovskaya
authors.forename: Erich R
authors.initials: ER
authors.lastname: Mackow
mesh_terms: D022005:Adherens Junctions / Q000378:metabolism*; D042683:Angiopoietin-1 / Q000378:metabolism; D015703:Antigens, CD / Q000378:metabolism*; D015820:Cadherins / Q000378:metabolism*; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism* / Q000821:virology*; D018063:Hantaan virus / Q000378:metabolism* / Q000472:pathogenicity; D006476:Orthohantavirus / Q000378:metabolism* / Q000472:pathogenicity; D006801:Humans; D008246:Lysophospholipids / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*; D000099152:Cadherin 5
chemical_list: D042683:Angiopoietin-1; D015703:Antigens, CD; D015820:Cadherins; D008246:Lysophospholipids; D013110:Sphingosine; D040301:Vascular Endothelial Growth Factor Receptor-2; D000099152:Cadherin 5; C060506:sphingosine 1-phosphate
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10664-9
references.pmid: 12963813
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1163-8
references.pmid: 15657120
references.citation: Braz J Med Biol Res. 1999 May;32(5):501-10
references.pmid: 10412560
references.citation: Curr Top Microbiol Immunol. 2001;256:91-115
references.pmid: 11217408
references.citation: Scand J Infect Dis Suppl. 1982;36:93-5
references.pmid: 6134335
references.citation: Science. 1999 Dec 24;286(5449):2511-4
references.pmid: 10617467
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7074-9
references.pmid: 9618541
references.citation: Proc Soc Exp Biol Med. 1999 Oct;222(1):29-38
references.pmid: 10510244
references.citation: J Exp Med. 1991 Nov 1;174(5):1275-8
references.pmid: 1940805
references.citation: Cell. 2002 Sep 6;110(5):599-11
references.pmid: 12230977
references.citation: Chest. 1997 Oct;112(4):1133-6
references.pmid: 9377934
references.citation: Thromb Res. 2007;120 Suppl 2:S1-6
references.pmid: 18023702
references.citation: Arch Virol. 2002 Oct;147(10):1913-31
references.pmid: 12376753
references.citation: Mol Cell Biol. 1996 Sep;16(9):4604-13
references.pmid: 8756616
references.citation: Am J Pathol. 1995 Mar;146(3):552-79
references.pmid: 7887439
references.citation: J Cell Sci. 2008 Jul 1;121(Pt 13):2115-22
references.pmid: 18565824
references.citation: Arch Virol. 1990;111(3-4):281-6
references.pmid: 2112908
references.citation: J Virol. 2008 Jun;82(12):5797-806
references.pmid: 18367532
references.citation: Trends Cardiovasc Med. 2006 Feb;16(2):55-9
references.pmid: 16473763
references.citation: J Virol. 1992 Oct;66(10):5929-36
references.pmid: 1356160
references.citation: Am J Respir Cell Mol Biol. 2000 Jun;22(6):657-64
references.pmid: 10837361
references.citation: Nat Cell Biol. 2006 Nov;8(11):1223-34
references.pmid: 17060906
references.citation: EMBO J. 1999 Feb 15;18(4):882-92
references.pmid: 10022831
references.citation: J Cell Biol. 2006 Aug 14;174(4):593-604
references.pmid: 16893970
references.citation: Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
references.pmid: 16633338
references.citation: Nat Med. 2002 Jan;8(1):27-34
references.pmid: 11786903
references.citation: Mol Cell. 2000 Oct;6(4):851-60
references.pmid: 11090623
references.citation: Blood. 2005 Jan 15;105(2):659-69
references.pmid: 15374877
references.citation: Am J Physiol Lung Cell Mol Physiol. 2006 Feb;290(2):L209-21
references.pmid: 16403941
references.citation: J Virol. 1999 May;73(5):3951-9
references.pmid: 10196290
references.citation: J Clin Invest. 1999 Jan;103(2):229-38
references.pmid: 9916135
references.citation: Nature. 2005 Sep 22;437(7058):497-504
references.pmid: 16177780
references.citation: Blood. 2008 Oct 15;112(8):3011-25
references.pmid: 18840725
references.citation: J Biol Chem. 2000 Dec 22;275(51):39867-73
references.pmid: 10964931
references.citation: Eur Respir J. 2006 Mar;27(3):600-6
references.pmid: 16507862
references.citation: Circ Res. 2000 Sep 29;87(7):603-7
references.pmid: 11009566
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L258-67
references.pmid: 12626332
references.citation: Am J Respir Crit Care Med. 2005 Sep 15;172(6):763-7
references.pmid: 15947284
references.citation: Emerg Infect Dis. 1997 Apr-Jun;3(2):95-104
references.pmid: 9204290
references.citation: Circ Res. 2006 Sep 29;99(7):675-91
references.pmid: 17008597
references.citation: J Cell Physiol. 2004 Jan;198(1):53-61
references.pmid: 14584044
references.citation: Semin Respir Crit Care Med. 2007 Apr;28(2):193-200
references.pmid: 17458773
references.citation: Br J Pharmacol. 2003 May;139(2):329-36
references.pmid: 12770938
references.citation: J Cell Biochem. 2004 Aug 15;92(6):1075-85
references.pmid: 15258893
references.citation: J Virol. 2010 May;84(9):4832-9
references.pmid: 20181715
references.citation: N Engl J Med. 1994 Apr 7;330(14):949-55
references.pmid: 8121458
references.citation: Exp Cell Res. 2006 Mar 10;312(5):522-6
references.pmid: 16430882
references.citation: Novartis Found Symp. 2007;283:4-13; discussion 13-7, 238-41
references.pmid: 18300410
references.citation: Crit Care Med. 2004 May;32(5 Suppl):S271-9
references.pmid: 15118530
references.citation: Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2108-14
references.pmid: 15345507
references.citation: Circ Res. 2007 Sep 14;101(6):570-80
references.pmid: 17641225
references.citation: Nat Med. 2000 Feb;6(2):131-2
references.pmid: 10655092
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1774-9
references.pmid: 16446427
references.citation: Hum Pathol. 1995 Jan;26(1):110-20
references.pmid: 7821907
references.citation: J Biol Chem. 1998 Jun 12;273(24):15099-103
references.pmid: 9614120
references.citation: Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):617-22
references.pmid: 11950700
references.citation: J Virol. 2010 Jan;84(1):352-60
references.pmid: 19846530
references.citation: EMBO J. 2002 Sep 16;21(18):4885-95
references.pmid: 12234928
references.citation: Am J Pathol. 1995 May;146(5):1029-39
references.pmid: 7538264
references.citation: J Biol Chem. 2009 Feb 6;284(6):3917-24
references.pmid: 19019827
references.citation: Dev Cell. 2008 Jan;14(1):25-36
references.pmid: 18194650
references.citation: Annu Rev Pathol. 2006;1:171-98
references.pmid: 18039112
references.citation: Cell Signal. 2007 Oct;19(10):2003-12
references.pmid: 17658244